CYCLOPHARM LIMITED

CYC

equity

AUD $1.50

0.005 (0.33%)

Updated: 20 Jan, 1:05 am UTC

Description

Cyclopharm Limited is an ASX-listed medical technology company focused on developing and commercialising innovative medical imaging products. Its flagship product, Technegas, is the world's only inhaled radioactive gas for medical imaging. Cyclopharm is also advancing the development of its next-generation imaging agent, TechnegasPlus, and has ongoing research and development projects to create a new range of products, such as a nuclear medicine camera. Its core objective is to provide a safe and effective imaging solution to improve patient care and outcomes.

Activity
Last price		$1.50
Change		0.005 (0.33%)
Bid/Ask		$1.49 - $1.50
Volume		10,436.00
Volume traded/total %		0.011%
Volume avg (4w)		12,821.00
Open		$1.51
Day range		$1.50 - $1.51
Previous Close		$1.50
Last Trade		20 Jan, 1:05 am UTC

Size
Market Cap		$139.12M
Market Rank		902
Industry Rank		42

Fundamentals
Shares Issued		93.05M
Earnings Per Share (EPS)		$-0.040
Dividends Per Share (DPS)		$0.010
P/E Ratio		-

Similar to